Harbor Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Harbor Capital Advisors's LLY Position: Q2 2026 in Review
Harbor Capital Advisors increased its Eli Lilly (LLY) stake by 0.2% in Q2 2026, buying an estimated $21.5K and bringing the position to 10,271 shares worth $12.3M. The position accounts for 0.84% of the portfolio, ranked #16.
Harbor Capital Advisors first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. The position peaked at $13.6M in Q2 2024. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Harbor Capital Advisors held 10,271 shares of Eli Lilly worth $12.3M as of Q2 2026.
- Harbor Capital Advisors bought 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
- Eli Lilly made up 0.84% of Harbor Capital Advisors's portfolio in Q2 2026, its #16 holding.
- Harbor Capital Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
- Harbor Capital Advisors's Eli Lilly position peaked at $13.6M in Q2 2024.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.